Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Anna Koclęga"'
Autor:
Martyna Wlodarczyk, Agata Wieczorkiewicz-Kabut, Krzysztof Białas, Anna Koclęga, Izabela Noster, Patrycja Zielińska, Grzegorz Helbig
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 1, Pp 9-15 (2024)
Objective: Cytomegalovirus (CMV) reactivation is a life-threatening complication after allogeneic hematopoietic stem cell transplantation (HSCT). Introduction of letermovir (LMV) seems to improve posttransplant outcomes, but delayed-onset CMV reactiv
Externí odkaz:
https://doaj.org/article/4372bd87ff6d440687b7a4798f652c40
Publikováno v:
Medicina, Vol 59, Iss 7, p 1209 (2023)
The occurrence of secondary neoplasms in adult patients treated with chemotherapy in childhood is not uncommon. Prior chemotherapy is found to be an independent risk factor for the development of secondary malignancies, which are usually associated w
Externí odkaz:
https://doaj.org/article/315da2e3109a46ef9bb77c0508cd2772
Autor:
Adrianna Spałek, Agata Wieczorkiewicz-Kabut, Anna Koclęga, Krzysztof Woźniczka, Patryk Węglarz, Kinga Boral, Dariusz Kata, Patrycja Zielińska, Grzegorz Helbig
Publikováno v:
International Journal of Hematology. 116:922-928
Steroid-refractory acute graft-versus-host disease (SR-aGVHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Ruxolitinib (RUX), an oral JAK1 and JAK2 inhibitor, has recently been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55a55754662d76f422d2fc30c7f3a619
https://doi.org/10.1007/s12185-022-03434-5
https://doi.org/10.1007/s12185-022-03434-5
Autor:
Katarzyna Duda, Agata Wieczorkiewicz-Kabut, Anna Koclęga, Patrycja Zielińska, Krzysztof Woźniczka, Helena Krzemień, Anna Armatys, Grzegorz Helbig
Publikováno v:
Annals of Hematology.
The incidence of AML increases with age. The implementation of reduced intensity conditioning and progress in supportive care enabled to perform allo-HSCT in elderly patients. The main objective of the study was to assess the safety and efficacy of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a01f86df1143ff7ce1781598121f91ea
https://doi.org/10.1007/s00277-023-05226-1
https://doi.org/10.1007/s00277-023-05226-1
Autor:
Patrycja Zielińska, Izabela Noster, Agata Wieczorkiewicz-Kabut, Krzysztof Białas, Anna Koclęga, Grzegorz Helbig
Publikováno v:
Polish Archives of Internal Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0c547bbaaa3e43a1fc1a6459703c016
https://doi.org/10.20452/pamw.16448
https://doi.org/10.20452/pamw.16448
Publikováno v:
Journal of Hematopathology. 14:277-281
Thymus and activation-regulated chemokine (TARC) is expressed on Reed-Sternberg cells of patients with classical Hodgkin lymphoma (HL) and may serve as a marker in response assessment. In our study, we correlated serum TARC levels with early response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::195666b55f36eae01d3dfef297e7aecd
https://doi.org/10.1007/s12308-021-00470-8
https://doi.org/10.1007/s12308-021-00470-8
Autor:
Anna Kopińska, Patryk Węglarz, Anna Koclęga, Agata Wieczorkiewicz-Kabut, Krzysztof Woźniczka, Anna Armatys, Adrianna Spałek, Iwona Grygoruk-Wiśniowska, Sebastian Grosicki, Aleksandra Butrym, Jarosław Czyż, Agata Obara, Tomasz Gromek, Grzegorz Helbig
Publikováno v:
Clinical lymphoma, myelomaleukemia.
Patients with relapsed/refractory acute myeloid leukemia (r/r AML) are characterized as having a poor prognosis. The only viable option of treatment for these patients is allogenic stem cell transplantation (allo-HSCT). Therefore, we have attempted t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e466a62b8810f3ff45958c3e853c8c90
https://pubmed.ncbi.nlm.nih.gov/36323603
https://pubmed.ncbi.nlm.nih.gov/36323603
Autor:
Adrianna Spałek, Agata Wieczorkiewicz-Kabut, Krzysztof Woźniczka, Anna Koclęga, Konrad Matlak, Dariusz Kata, Grzegorz Helbig, Anna Armatys
Publikováno v:
Acta Haematologica Polonica. 52:103-109
Introduction: Therapy-related acute myeloid leukemia (t-AML) remains a late consequence of exposure to cytotoxic chemo- and/or radiotherapy for prior malignant or non-malignant disorders. The prognosis of t-AML is extremely poor, and allogeneic stem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6a8a294c78adb7eb86d022668346032
https://doi.org/10.5603/ahp.2021.0016
https://doi.org/10.5603/ahp.2021.0016
Autor:
Agata Wieczorkiewicz-Kabut, Anna Koclęga, Anna Armatys, Marta Panz-Klapuch, Dariusz Kata, Krzysztof Wozniczka, Grzegorz Helbig, Anna Kopińska
Publikováno v:
Neoplasma. 67:1431-1436
High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (ASCT) remains a valuable therapeutic approach for relapsed and refractory (R/R) patients with diffuse large B-cell lymphoma (DLBCL). The aim of the study was to ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a45c511b35d1fca52ec023ea779bc1c
https://doi.org/10.4149/neo_2020_200303n224
https://doi.org/10.4149/neo_2020_200303n224
Autor:
Michał Razik, Patrycja Rozwadowska, Anna Koclęga, Kinga Boral, Martyna Dworaczek, Agata Wieczorkiewicz-Kabut, Grzegorz Helbig
Publikováno v:
Acta Haematologica Polonica. 53:355-356
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7ae6e8de2f052b266553e9c07832bd1
https://doi.org/10.5603/ahp.a2022.2048
https://doi.org/10.5603/ahp.a2022.2048